DEC 27, 2016 07:41 PM PST

Super-Enhancers Implicated in Autoimmune Disease

WRITTEN BY: Kara Marker

Regulatory T cells (Tregs) step in to mute the immune system after it has mounted a response against whatever foreign invader is tormenting the body. An immune attack is necessary to keep the body protected from invaders, but at a certain point Tregs ensure that the immune system does not go overboard and hurt healthy human cells, causing autoimmune disease.

Source: EpiBeat

The current study from the Immunology Frontier Research Center (IFReC) at Osaka University in Japan thusly focused on the origin of Tregs, of the precursor cells that are destined to become the specialized T cells that prevent autoimmune reactions.

They found that Treg development, which occurs in the thymus, is controlled by the establishment of super-enhancers, regulators of gene expression that appear to also be involved in Treg development.  “Super-enhancers appeared to be a pre-requisite for Treg cell development, so we sought molecules controlling super-enhancers,” explained IFReC professor Shimon Sakaguchi.

They found that the molecular mechanism behind Treg malfunction, which causes autoimmune diseases, was a protein called Satb1, which the observed as a regulator of the super-enhancers essential for Treg cell development.

Satb1 levels are inherently highest just before Tregs develop, and there is a sudden reduction right after they eventually develop. This connection is due to the bond between Satb1 and the super-enhancers responsible for Treg development, researchers found, but Satb1 is not bound to the Tregs themselves.

“Satb1 appears to be necessary for the differentiation of Treg cells but not for the maintenance of Treg cells,” explained first author Dr. Yohko Kitagawa.

During their study, mutant mice lacking Satb1 showed impaired Treg development and signs of autoimmune disease. Additionally, Treg progenitor cells exhibited inferior super enhancer activity, leading to a reduction in expression of vital genes for Treg development.

Ultimately, Sakaguchi, Kitagawa, and the rest of the research team concluded that a lack of ample Satb1-dependent super-enhancers could be causing autoimmune diseases and allergies in some people, a result that leaves room for future research into Satb1 as a target for treating these conditions.

The current study was recently published in the journal Nature Immunology.

Sources: Osaka University, Immunology Frontier Research CenterNature Genetics

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 15, 2019
Immunology
SEP 15, 2019
When a Virus Infects Bacteria
Researchers have used P. aeruginosa as a 'model system' for understanding how bacteria's interactions with viruses may affect human health....
SEP 15, 2019
Immunology
SEP 15, 2019
What We Don't Know Won't Hurt Us, Right?
A review in Frontiers in Pediatrics describes a common food additive that could both create and trigger autoimmune attacks, calling for warnings on food labels pending further tests....
SEP 15, 2019
Health & Medicine
SEP 15, 2019
Bartonella henselae Infection Implicated in Pediatric Acute-Onset Neuropsychiatric Syndrome
Pediatric acute-onset neuropsychiatric syndrome (PANS) is a term used to describe every cause of acute-onset of obsessive-compulsive disorder including str...
SEP 15, 2019
Cancer
SEP 15, 2019
Widely Prescribed Breast Cancer Medication Promotes Metastasis
The primary goals of metastatic breast cancer treatment are to ensure that the patient has the longest survival possible while experiencing the highes...
SEP 15, 2019
Health & Medicine
SEP 15, 2019
Drug-resistant Candida Auris is Spreading
A drug-resistant fungal yeast, Candida auris, is spreading throughout hospitals worldwide. Deemed “an urgent threat” by the Center for Disease...
SEP 15, 2019
Drug Discovery
SEP 15, 2019
Novel Treatments for Auto-immune Disorders
A recent research study examined a library of almost 300,000 small molecules to search for a molecule that may be a potential target for the human GMP-AMP ...
Loading Comments...